WHO issues global guideline on the use of GLP-1 medicines in treating obesity

To address the growing global health challenge of obesity, the World Health Organization (WHO) has released its first guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic, relapsing disease.